BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29748098)

  • 1. Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.
    Singla N; Krabbe LM; Aydin AM; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V
    Urol Oncol; 2018 Jul; 36(7):343.e1-343.e8. PubMed ID: 29748098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
    Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
    Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
    Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
    Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
    Song SH; Ye CH; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2863-2870. PubMed ID: 31501983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
    Aydin AM; Singla N; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Westerman ME; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V; Krabbe LM
    World J Urol; 2019 Nov; 37(11):2419-2427. PubMed ID: 30759271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
    Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
    BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.
    Xu H; Ai JZ; Tan P; Lin TH; Jin X; Gong LN; Lei HR; Yang L; Wei Q
    Asian J Androl; 2020; 22(2):177-183. PubMed ID: 31169138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.
    Kido K; Hatakeyama S; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Iwabuchi I; Ogasawara M; Kawaguchi T; Ohyama C
    Int J Clin Oncol; 2018 Aug; 23(4):726-733. PubMed ID: 29435873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location.
    Lee HY; Li CC; Huang CN; Ke HL; Li WM; Liang PI; Yang SF; Tu HP; Wu WJ; Yeh HC
    Ann Surg Oncol; 2015 Apr; 22(4):1392-400. PubMed ID: 25239005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study.
    Milojevic B; Bumbasirevic U; Santric V; Kajmakovic B; Dragicevic D; Radisavcevic D; Sretenovic M; Grujicic SS
    Curr Probl Cancer; 2021 Dec; 45(6):100747. PubMed ID: 33883080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching.
    Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mizuno R; Oya M
    Ann Surg Oncol; 2019 Oct; 26(11):3774-3781. PubMed ID: 31313043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of AIB1 expression on the prognosis of upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang Y; Cen J; Wei J; Chen Z; Fang Y; Feng Z; Lu J; Liang Y; Luo J; Mo C; Chen W
    Cancer Biomark; 2019; 25(2):151-160. PubMed ID: 31045512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.